Aspire Biopharma Hldgs Inc.

13F holders, Q1 2025 (March 31)
15holders
1famous investor
$0.61avg. 13F price*

At the end of Q1 2025, 15 institutions reported holding Aspire Biopharma Hldgs Inc. in their 13F filings. The largest holders were Toronto Dominion Bank ($350K), Crewe Advisors LLC ($183K) and Harraden Circle Investments, LLC ($87K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Aspire Biopharma Hldgs Inc.
CUSIP
738920107
Latest filing quarter
Q2 2026

History

Number of 13F holders

0102030 Q1 2025: 15Q1 2025Q2 2025: 16Q2 2025Q3 2025: 25Q3 2025Q4 2025: 30Q4 2025Q1 2026: 2Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q1 2025

InstitutionsTotal Value
New Positions15$876K
Exits0$0

Ownership 15 holders

Toronto Dominion Bank 0.00% New 516,845 $350K
Crewe Advisors LLC 0.03% New 313,427 $183K
Harraden Circle Investments, LLC 0.04% New 150,000 $87K
Optivise Advisory Services LLC 0.03% New 106,446 $62K
Procyon Advisors, LLC 0.00% New 98,500 $57K
Periscope Capital Inc. 0.02% New 75,000 $34K
Platform Technology Partners 0.01% New 37,611 $22K
UBS Group AG 0.00% New 29,945 $17K
Two Sigma Securities, LLC 0.00% New 27,413 $16K
Citadel Advisors 0.00% New 26,901 $16K
Jane Street Group, LLC 0.00% New 21,019 $12K
Virtu Financial LLC 0.00% New 16,694 $10K
Susquehanna International Group, LLP 0.00% New 16,023 $9K
Reyes Financial Architecture, Inc. 0.00% New 140 $82
Farther Finance Advisors, LLC 0.00% New 20 $12

"% of holder's portfolio" is ASPIRE BIOPHARMA HLDGS INC's weight in each manager's 13F, not the share of Aspire Biopharma Hldgs Inc. the manager owns.